Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 69
Filter
1.
Eur Radiol ; 33(12): 8999-9009, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37402003

ABSTRACT

OBJECTIVE: To validate the proton density fat fraction (PDFF) obtained by the MRQuantif software from 2D chemical shift encoded MR (CSE-MR) data in comparison with the histological steatosis data. METHODS: This study, pooling data from 3 prospective studies spread over time between January 2007 and July 2020, analyzed 445 patients who underwent 2D CSE-MR and liver biopsy. MR derived liver iron concentration (MR-LIC) and PDFF was calculated using the MRQuantif software. The histological standard steatosis score (SS) served as reference. In order to get a value more comparable to PDFF, histomorphometry fat fraction (HFF) were centrally determined for 281 patients. Spearman correlation and the Bland and Altman method were used for comparison. RESULTS: Strong correlations were found between PDFF and SS (rs = 0.84, p < 0.001) or HFF (rs = 0.87, p < 0.001). Spearman's coefficients increased to 0.88 (n = 324) and 0.94 (n = 202) when selecting only the patients without liver iron overload. The Bland and Altman analysis between PDFF and HFF found a mean bias of 5.4% ± 5.7 [95% CI 4.7, 6.1]. The mean bias was 4.7% ± 3.7 [95% CI 4.2, 5.3] and 7.1% ± 8.8 [95% CI 5.2, 9.0] for the patients without and with liver iron overload, respectively. CONCLUSION: The PDFF obtained by MRQuantif from a 2D CSE-MR sequence is highly correlated with the steatosis score and very close to the fat fraction estimated by histomorphometry. Liver iron overload reduced the performance of steatosis quantification and joint quantification is recommended. This device-independent method can be particularly useful for multicenter studies. CLINICAL RELEVANCE STATEMENT: The quantification of liver steatosis using a vendor-neutral 2D chemical-shift MR sequence, processed by MRQuantif, is well correlated to steatosis score and histomorphometric fat fraction obtained from biopsy, whatever the magnetic field and the MR device used. KEY POINTS: • The PDFF measured by MRQuantif from 2D CSE-MR sequence data is highly correlated to hepatic steatosis. • Steatosis quantification performance is reduced in case of significant hepatic iron overload. • This vendor-neutral method may allow consistent estimation of PDFF in multicenter studies.


Subject(s)
Fatty Liver , Iron Overload , Non-alcoholic Fatty Liver Disease , Humans , Protons , Prospective Studies , Liver/diagnostic imaging , Liver/pathology , Magnetic Resonance Imaging/methods , Fatty Liver/diagnostic imaging , Fatty Liver/pathology , Iron Overload/diagnostic imaging , Non-alcoholic Fatty Liver Disease/diagnostic imaging , Non-alcoholic Fatty Liver Disease/pathology
3.
Cancer Radiother ; 22(8): 797-801, 2018 Dec.
Article in French | MEDLINE | ID: mdl-30523795

ABSTRACT

Patients with hepatocellular carcinoma who are on liver transplant waiting list usually require local treatment to limit any risk of tumour growth. Historically percutaneous radiofrequency ablation or transarterial chemoembolization represented the major therapeutic alternatives. Depending on the size, or the topography of the lesion these two techniques may not be feasible. Radiation therapy under stereotactic conditions has recently emerged in the management of localized hepatocellular carcinoma as an alternative to the focused therapies performed to date. We herein report the case of a 43-year-old patient harbouring a complete histological response on explant after liver stereotactic irradiation and discuss its role in the management of hepatocellular carcinoma before liver transplantation.


Subject(s)
Carcinoma, Hepatocellular/radiotherapy , Liver Neoplasms/radiotherapy , Liver Transplantation , Radiosurgery , Adult , Carcinoma, Hepatocellular/surgery , Combined Modality Therapy , Contraindications, Procedure , Dose Fractionation, Radiation , Female , Heparin, Low-Molecular-Weight/therapeutic use , Humans , Liver Neoplasms/surgery , Radiosurgery/methods , Remission Induction , Vena Cava Filters , Vena Cava, Inferior , Venous Thrombosis/complications , Venous Thrombosis/drug therapy , Venous Thrombosis/therapy
4.
J Visc Surg ; 155(5): 375-382, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29289459

ABSTRACT

BACKGROUND: To evaluate the performance of CT-scans performed one week after pancreato-duodenectomy (PD) to detect severe postoperative complications requiring an invasive treatment. PATIENTS AND METHODS: This monocentric retrospective study was conducted on data collected between 2005 and 2013. Patients undergoing PD underwent CT-scan with IV contrast at the end of the first postoperative week. The results of the CT-scans were analyzed to evaluate the usefulness of this procedure. The main assessment criterion was the occurrence of type-III complication (or greater) according to the Dindo-Clavien classification. RESULTS: In total, 138 patients were included. The mortality rate was 2.2%. The postoperative complication rate was 57.2%. The pancreatic fistula rate was 19.6%; 46 patients (33.3%) presented with a severe complication. A total of 138 CT-scans were analyzed: 44 (31.8%) were abnormal, 94 (68.2%) were normal. Among patients with abnormal CT-scans, 17 (39%) presented with a severe complication requiring an invasive treatment. Among the 94 patients with normal CT-scans, 14 patients (15%) presented a severe postoperative complication. Evaluation of the performance of the CT-scans at the end of the first postoperative week found a sensitivity of 55%, a specificity of 75%, a positive predictive value of 39%, and a negative predictive value of 85%. CONCLUSION: Systematic CT-scans performed at the end of the first postoperative week do not effectively detect severe complications after PD and do not help to prevent them.


Subject(s)
Pancreatic Fistula/diagnostic imaging , Pancreaticoduodenectomy/adverse effects , Postoperative Complications/diagnostic imaging , Tomography, X-Ray Computed , Adult , Aged , Aged, 80 and over , Contrast Media , Humans , Middle Aged , Pancreatic Fistula/epidemiology , Pancreatic Fistula/therapy , Pancreaticoduodenectomy/methods , Pancreaticoduodenectomy/mortality , Postoperative Complications/epidemiology , Postoperative Complications/mortality , Postoperative Complications/therapy , Predictive Value of Tests , Retrospective Studies , Sensitivity and Specificity , Tomography, X-Ray Computed/statistics & numerical data
6.
Diagn Interv Imaging ; 96(7-8): 807-21, 2015.
Article in English | MEDLINE | ID: mdl-26188637

ABSTRACT

Several mechanisms predispose to bleeding in neoplastic disease. This is all the more serious as it often occurs on a background of medically vulnerable patients and the magnitude of the bleed may lead to hemorrhagic shock or acute respiratory distress as a result of hemoptysis. It often carries a poor prognosis, even if the acute episode has been controlled, as bleeding due to rupture of a tumor often indicates an advanced stage of the disease, and also because tumor rupture carries a risk of metastatic spread including peritoneal carcinomatosis. The risk of recurrent bleeding is also not insignificant. In most cases, endovascular hemostatic embolization is the first line palliative treatment.


Subject(s)
Embolization, Therapeutic/methods , Hemorrhage/etiology , Hemorrhage/therapy , Neoplasms/blood supply , Neoplasms/complications , Angiography , Hemoptysis/etiology , Hemoptysis/therapy , Hemorrhage/diagnosis , Humans , Neoplasm Staging , Neoplasms/pathology , Neoplastic Cells, Circulating , Neovascularization, Pathologic/complications , Neovascularization, Pathologic/therapy , Prognosis , Recurrence , Risk Factors , Rupture, Spontaneous , Shock, Hemorrhagic/etiology , Shock, Hemorrhagic/therapy , Tomography, X-Ray Computed
8.
Int J Hepatol ; 2011: 791013, 2011.
Article in English | MEDLINE | ID: mdl-22135750

ABSTRACT

Background. Sorafenib is a molecular-targeted therapy used in palliative treatment of advanced hepatocellular carcinoma in Child A patients. Aims. To address the question of sorafenib as neoadjuvant treatment. Methods. We describe the cases of 2 patients who had surgery after sorafenib. Results. The patients had a large hepatocellular carcinoma in the right liver with venous neoplastic thrombi (1 in the right portal branch, 1 in the right hepatic vein). After 9 months of sorafenib, reassessment showed that tumours had decreased in size with a necrotic component. A right hepatectomy with thrombectomy was performed, and histopathology showed 35% to 60% necrosis. One patient had a recurrence after 6 months and had another liver resection; they are both recurrence-free since then. Conclusion. Sorafenib can downstage hepatocellular carcinoma and thus could represent a bridge to surgery. It may be possible to select patients in good general condition with partial regression of the tumour with sorafenib for a treatment in a curative intent.

9.
J Endocrinol Invest ; 34(9): e253-8, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21623151

ABSTRACT

BACKGROUND: Preventing hypoglycemia is of vital importance and a major challenge in patients with severe symptomatic hypoglycemia related to malignant unresectable insulinomas, but there is no consensus treatment. PATIENTS: Five patients with malignant unresectable insulinomas were referred to our department for severe hypoglycemia. At referral the five patients were dependent on iv infusion of glucose solution. Patient 1 had a locally invasive 5-cm insulinoma, patients 2, 3 and 4 had multiple liver metastases and patient 5 had a 2.5-cm pancreatic tumor with multiple liver and lung metastases. Before referral to our department, 4/5 patients had been administered systemic chemotherapy and 3/5 therapeutic doses of radiolabeled octreotide without any benefit on blood glucose levels. Octreoscan scintigraphy was positive in 4 patients (patients 1-4). Diazoxide alone or combined with glucocorticoids had failed to control hypoglycemia. Continuous sc administration of octreotide (up to 1500 µg/day) resulted in normalization of blood glucose levels in patient 1. Chemoembolization of liver metastases normalized blood glucose levels in patient 2, minimized hypoglycemia in patients 3 and 4, and normalized blood glucose levels in patient 5 when followed by subcutaneous administration of octreotide (2000 µg/day). Chemoembolization had to be repeated four times in patient 3 to control blood glucose levels. CONCLUSION: Chemoembolization of liver metastases and high-dose octreotide in responsive patients (alone or combined with chemoembolization) can control severe hypoglycemia in patients with symptomatic malignant unresectable insulinomas; the efficacy of octreotide can be improved after chemoembolization of liver metastases.


Subject(s)
Embolization, Therapeutic , Hypoglycemia , Insulinoma , Liver Neoplasms , Octreotide/therapeutic use , Somatostatin/analogs & derivatives , Somatostatin/therapeutic use , Adult , Aged , Female , Humans , Hypoglycemia/drug therapy , Hypoglycemia/etiology , Hypoglycemia/therapy , Insulinoma/complications , Insulinoma/drug therapy , Insulinoma/therapy , Liver Neoplasms/complications , Liver Neoplasms/drug therapy , Liver Neoplasms/therapy , Male , Middle Aged , Radionuclide Imaging
10.
J Radiol ; 91(9 Pt 1): 857-77, 2010 Sep.
Article in French | MEDLINE | ID: mdl-20814374

ABSTRACT

The CT and MR imaging features of the main cardiac tumors will be reviewed. Cross-sectional imaging features may help differentiate between cardiac tumors and pseudotumoral lesions and identify malignant features. Based on clinical features, imaging findings are helpful to further characterize the nature of the lesion. CT and MR imaging can demonstrate the relationship of the tumor with adjacent anatomical structures and are invaluable in the presurgical work-up and postsurgical follow-up.


Subject(s)
Heart Neoplasms/diagnosis , Image Enhancement , Image Processing, Computer-Assisted , Magnetic Resonance Imaging , Tomography, X-Ray Computed , Diagnosis, Differential , Heart Atria/pathology , Heart Neoplasms/pathology , Heart Neoplasms/secondary , Heart Neoplasms/surgery , Heart Septum/pathology , Heart Valves/pathology , Heart Ventricles/pathology , Humans , Incidental Findings , Lipoma/diagnosis , Lipoma/pathology , Lipoma/surgery , Liposarcoma/diagnosis , Liposarcoma/pathology , Liposarcoma/surgery , Mesothelioma/diagnosis , Mesothelioma/pathology , Mesothelioma/surgery , Myxoma/diagnosis , Myxoma/pathology , Myxoma/surgery , Sarcoma/diagnosis , Sarcoma/pathology , Sarcoma/surgery , Sensitivity and Specificity
11.
J Radiol ; 91(9 Pt 1): 885-94, 2010 Sep.
Article in French | MEDLINE | ID: mdl-20814376

ABSTRACT

PURPOSE: Radiofrequency thermal ablation (TA) of lung tumors currently is considered an alternative to surgical management for early primary lung cancers and non-surgical lung metastases. The purpose of this study was to determine the tolerability and efficacy of this treatment in 29 consecutive patients, most of which with primary lung cancers, managed in our center. MATERIALS AND METHODS: Twenty-nine patients with 32 lung tumors less than 35 mm in diameter underwent radiofrequency thermal ablation between May 2004 and July 2008. The CT examinations performed during and after the ablation were reviewed to determine lesion characteristics, complications, treatment, local recurrence rate and survival rate. RESULTS: Sixty-nine percent of our population consisted of primary lung cancer. The incidence of pneumothorax was 72% with 10% requiring drainage. The rate of complete response was 81%. The survival rate at 1 year was 79%. CONCLUSION: Radiofrequency thermal ablation of lung tumors is a minimally invasive technique with high rate of complete response. It can be considered in non-surgical patients with primary or metastatic lung tumors less than 35 mm in diameter.


Subject(s)
Carcinoma, Bronchogenic/surgery , Catheter Ablation/instrumentation , Lung Neoplasms/surgery , Surgery, Computer-Assisted/instrumentation , Tomography, X-Ray Computed/instrumentation , Aged , Aged, 80 and over , Carcinoma, Bronchogenic/diagnostic imaging , Carcinoma, Bronchogenic/pathology , Electrodes , Feasibility Studies , Female , Follow-Up Studies , Humans , Lung/pathology , Lung/surgery , Lung Neoplasms/diagnostic imaging , Lung Neoplasms/pathology , Lung Neoplasms/secondary , Male , Middle Aged , Patient Care Team , Postoperative Complications/diagnostic imaging
12.
Rev Mal Respir ; 26(7): 744-50, 2009 Sep.
Article in French | MEDLINE | ID: mdl-19953016

ABSTRACT

INTRODUCTION: Superior vena cava obstruction is an urgent complication of lung cancer. Superior vena cava stent insertion can be considered to provide rapid relief of the symptoms. METHODS: To estimate the efficiency and the complications of this procedure, we retrospectively analyzed 41 consecutive patients treated during the last 5 years by self-expanding nitinol stent insertion for superior vena cava obstruction due to lung cancer. It was combined with anticoagulation and corticosteroids. RESULTS: 41 patients benefited from this treatment (30 men and 11 women) with an average age of 59 years. Etiologies of the vena cava obstruction were: small cell carcinoma (11), adenocarcinoma (8), squamous cell carcinoma (9), large cell carcinoma (9) and others (4). All patients were symptomatic. The average period between the onset of symptoms and the vascular stenting was 14 days. Specific treatment was chemotherapy (18 patients), radiotherapy (1 patient), or both (14 patients), and no specific treatment for 6 patients. The procedure consisted of the insertion of 1 (73%) or 2 (27%) stents, with an average length and caliber of 7.5 cm and 14 mm respectively. No major complication was reported in short and long-term follow up. Symptomatic improvement was observed for all the patients within 48 hours. Median survival after the stenting was of 6.7 months. CONCLUSION: In our study, vascular stenting for malignant superior cava vena obstruction allows a rapid improvement of the symptoms with very few complications, suggesting a possible role as first line treatment for chemo or radio-resistant tumours.


Subject(s)
Adenocarcinoma/complications , Blood Vessel Prosthesis Implantation , Carcinoma, Non-Small-Cell Lung/complications , Carcinoma, Squamous Cell/complications , Lung Neoplasms/complications , Small Cell Lung Carcinoma/complications , Stents , Superior Vena Cava Syndrome/surgery , Adult , Aged , Data Interpretation, Statistical , Female , Follow-Up Studies , Humans , Male , Middle Aged , Recurrence , Retrospective Studies , Superior Vena Cava Syndrome/etiology , Superior Vena Cava Syndrome/mortality , Superior Vena Cava Syndrome/therapy , Time Factors
13.
J Chir (Paris) ; 146(2): 191-4, 2009 Apr.
Article in French | MEDLINE | ID: mdl-19535077

ABSTRACT

Major abdominal surgery may be contraindicated in patients with cirrhosis because of the high risk of intraoperative bleeding and postoperative decompensation. Careful preparation of these patients is essential, aimed especially at reducing portal hypertension. We report the case of a patient with cirrhosis complicated by hepatocellular carcinoma, whose portal hypertension manifested almost exclusively by reanastomosis from the umbilical vein. A transjugular intrahepatic portosystemic shunt (TIPS) was placed before surgery to prepare the patient for hepatic resection. In addition to the singularity of the presentation of portal hypertension, this case prompts us to consider neoadjuvant TIPS as a means of preparing these at-risk patients for major abdominal surgery.


Subject(s)
Carcinoma, Hepatocellular/surgery , Hypertension, Portal/complications , Liver Cirrhosis, Alcoholic/complications , Liver Neoplasms/surgery , Portasystemic Shunt, Surgical , Preoperative Care , Carcinoma, Hepatocellular/complications , Female , Humans , Liver Neoplasms/complications , Middle Aged
14.
J Radiol ; 89(11 Pt 2): 1855-70, 2008 Nov.
Article in French | MEDLINE | ID: mdl-19106843

ABSTRACT

Multidetector CT is very useful in the evaluation of polytrauma patients. MDCT is valuable for the detection and treatment planning of vascular injuries, but it may not be available to hemodynamically unstable patients. Embolization of visceral and parietal branches of the aorta benefits from advances in catheter technology: hydrophilic catheters and microcatheters are very helpful in this context. Resorbable particles (such as gelatin) and coils are the most useful occlusive agents. Endovascular stenting of aortic rupture is nowadays considered in many centers as the best therapeutic option and can be proposed as an alternative to surgery.


Subject(s)
Abdominal Injuries/diagnostic imaging , Abdominal Injuries/therapy , Radiography, Interventional , Thoracic Injuries/diagnostic imaging , Thoracic Injuries/therapy , Embolization, Therapeutic , Humans , Male , Middle Aged
15.
Prog Urol ; 18(6): 372-8, 2008 Jun.
Article in French | MEDLINE | ID: mdl-18558327

ABSTRACT

OBJECTIVE: To study the results of balloon nephrostomy urine drainage in the treatment of lower urinary tract fistula. MATERIAL AND METHODS: A series of 10 patients with lower urinary tract fistula was treated by balloon nephrostomy for tumour in eight cases and trauma in two cases with a palliative indication in two patients. RESULTS: The duration of diversion ranged from seven to 210 days (mean: 55 days). The only incidents observed were three cases of urinary sepsis and four cases of nephrostomy tube or balloon migration. On removal of the nephrostomy, there were no signs of stenosis or other ureteric lesion. Balloon nephrostomy drainage achieved cure of the fistula in four cases, and allowed successful surgical repair in the other cases. CONCLUSION: Balloon nephrostomy placement appears to constitute an alternative to surgical repair for lower urinary tract fistula. In the case of failure, it appears to allow surgical repair to be performed under better conditions than in the case of immediate surgery. However, these preliminary results need to be confirmed on larger series.


Subject(s)
Catheterization , Nephrostomy, Percutaneous/methods , Ureteral Obstruction/therapy , Urinary Fistula/surgery , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Nephrostomy, Percutaneous/adverse effects , Palliative Care , Time Factors , Treatment Failure , Ureteral Obstruction/etiology , Ureteral Obstruction/surgery , Urinary Bladder Fistula/etiology , Urinary Bladder Fistula/surgery , Urinary Bladder Fistula/therapy , Urinary Fistula/etiology
16.
Am J Transplant ; 8(8): 1744-8, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18557740

ABSTRACT

Hepatitis E virus (HEV) infection was thought to be responsible for acute hepatitis that did not become chronic. However, we have recently reported that HEV infection can evolve to chronic hepatitis, at least in solid-organ transplant patients. We report on two cases of rapidly progressive of HEV-related cirrhosis that occurred in two organ-transplant patients. Case 1: A kidney-pancreas-transplant patient developed acute HEV hepatitis 60 months after transplantation, which evolved to chronicity as defined by persisting elevated liver-enzyme levels and positive serum HEV RNA. At 22 months after the acute phase, she presented with cirrhosis and portal hypertension, that is ascites and esophagus varices. Case 2: A kidney-transplant patient developed acute hepatitis 36 months after transplantation, which persisted and remained unexplained for 38 months. Then, HEV RNA was searched for in their serum and stools, and was found to be positive in both. Retrospective analysis of available stored serum, mainly the serum obtained at the acute phase, confirmed the diagnosis of chronic hepatitis E. In both cases, a liver biopsy showed cirrhosis. We conclude that HEV infection cannot only evolve to chronic hepatitis, but can also be responsible for rapidly progressing cirrhosis in organ-transplant patients.


Subject(s)
Hepatitis E virus/isolation & purification , Hepatitis E/diagnosis , Liver Cirrhosis/virology , Adult , Female , Humans , Kidney Transplantation , Liver Function Tests , Male , Middle Aged , Pancreas Transplantation , RNA, Viral
17.
J Radiol ; 88(9 Pt 2): 1261-3, 2007 Sep.
Article in French | MEDLINE | ID: mdl-17878872

ABSTRACT

The daily practice of radiologists has evolved and radiologists are increasingly being directly involved with patient care and treatment. Consequently, radiologists have become a part of the therapeutic team available to patients. This active role, in hospital based or out-patient practices, does not only have an impact on the radiologist's professional activities. New liabilities related to interventional procedures or treatments are now added to already existing professional liability from diagnostic activities. Therefore, musculoskeletal radiologists performing interventional procedures must be aware and familiar with their obligations towards patients, including the requirement to provide adequate information to patients and documenting that informed consent was obtained.


Subject(s)
Bone Diseases/therapy , Disclosure/legislation & jurisprudence , Informed Consent/legislation & jurisprudence , Liability, Legal , Muscular Diseases/therapy , Radiology, Interventional/legislation & jurisprudence , Ambulatory Care/legislation & jurisprudence , Consent Forms/legislation & jurisprudence , France , Humans , Medical Staff, Hospital/legislation & jurisprudence , Patient Care Team/legislation & jurisprudence
18.
Eur J Endocrinol ; 156(1): 21-31, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17218722

ABSTRACT

ACTH-independent macronodular adrenocortical hyperplasia (AIMAH) is rare and generally presents as a sporadic disease. We describe a familial case of AIMAH with in vivo and in vitro demonstration of aberrant 5-HT4 and vasopressin adrenal receptors. Two sisters presented with clinical and biological features of mild Cushing's syndrome with bilateral macronodular adrenal enlargement on computerized tomography (CT)-scan evaluation. In vivo pharmacological tests showed a significant increase in plasma cortisol after terlipressin and metoclopramide administration. Unilateral adrenalectomy was performed in one of these patients. Reverse transcriptase-PCR analysis of the hyperplastic tissue revealed expression of 5-HT4 receptor isoforms (a), (b), (c), (i), and (n), and of vasopressin receptors, V1 and V2. Their father and brother were overweight, had easy bruisability and presented with biological features of subclinical Cushing's syndrome. CT scan showed moderate adrenal enlargement. In vivo pharmacological screening tests for the detection of adrenal aberrant receptors in the brother were negative. Finally, three out of the two sisters' children were evaluated. They had neither clinical nor biological features of Cushing's syndrome. Their adrenal glands were normal on CT-scan evaluation. In vivo evaluation for the detection of aberrant adrenocortical receptors performed in one of these subjects was negative. In conclusion, this study shows that (i) familial AIMAH could be an autosomal dominantly inherited disorder; (ii) aberrant 5-HT4 serotonin and vasopressin receptors can be expressed in familial AIMAH; and (iii) phenotypic expression of familial AIMAH could be varied in a same family and more pronounced in female than in male patients.


Subject(s)
Adrenal Glands/metabolism , Adrenal Hyperplasia, Congenital/metabolism , Adrenocorticotropic Hormone/physiology , Receptors, Serotonin/metabolism , Receptors, Vasopressin/metabolism , Adrenal Hyperplasia, Congenital/diagnostic imaging , Adrenal Hyperplasia, Congenital/physiopathology , Aged, 80 and over , Cushing Syndrome/diagnosis , Cushing Syndrome/metabolism , Diabetes Mellitus, Type 2/complications , Female , Glucose Intolerance/complications , Humans , Hydrocortisone/blood , Hypertension/complications , Male , Middle Aged , Pedigree , Receptors, Serotonin/genetics , Receptors, Serotonin, 5-HT4/biosynthesis , Receptors, Serotonin, 5-HT4/genetics , Receptors, Vasopressin/genetics , Reverse Transcriptase Polymerase Chain Reaction , Tomography, X-Ray Computed
19.
Semin Intervent Radiol ; 24(2): 167-79, 2007 Jun.
Article in English | MEDLINE | ID: mdl-21326794

ABSTRACT

Type A aortic dissection remains fatal if untreated. Although classical medical therapy for type B dissection is considered the therapy of choice in uncomplicated cases, the paradigm is changing as greater experience is accrued with endovascular treatments and technical advances improve the long-term outlook. Diagnosis is also becoming more sophisticated, allowing greater appreciation of the anatomy of dissections and improving the knowledge base as their natural history is assessed.

20.
J Radiol ; 87(6 Pt 1): 619-38, 2006 Jun.
Article in French | MEDLINE | ID: mdl-16788536

ABSTRACT

The development of new imaging modalities such as computed tomography and magnetic resonance imaging is a new phenomenon in thanatology. The growing accessibility to these technologies allows, under some conditions, the acquisition of cross-sectional images on cadavers. The authors present a practical pictorial review of post-mortem changes and deadly injuries, illustrating the contributions of modern cross-sectional imaging techniques in thanatology.


Subject(s)
Magnetic Resonance Imaging , Postmortem Changes , Tomography, X-Ray Computed , Adolescent , Adult , Aged , Aged, 80 and over , Cause of Death , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...